In the development of pharmaceuticals, demonstrating that a drug remains unchanged in terms of identity, strength, quality, and purity between the time of manufacture to administration to the patient is a type of regulatory criterion. The critical evidence of this claim is given by stability studies. These tests recreate and speed up the effects of extended storage to forecast the actions of a product, to determine the route of degradation, and to assist in the creation, packaging, and labelling choices. A drug cannot be marketed without successful stability data.
Fundamental Principles
Stability testing is based on the Arrhenius equation, which characterises the dependence of the temperature on the rate of chemical degradation: with each 10°C rise in temperature, the rate of a great number of chemical reactions approximately doubles. The fundamental goals are to identify the time interval of retesting a drug substance, the shelf life of a processed product, the advisable storage conditions, and the key degradation pathways and products.
Key Testing Parameters & Analytical Methods
Dissolution/Disintegration: In solid oral dosage forms, tested under USP apparatus to ensure that the drug is released over time.
Functionality Testing: In the case of delivery devices, such as inhalers or injector pens, which are to be delivered. The methods should be stability-indicated, i.e., they should be able to detect the changes in the analyte when the degradation products of the analyte are present.
Regulatory Guidelines & The ICH Framework
The worldwide standard is the International Council for Harmonisation (ICH): the ICH Q1A (R2) outlines the basic stability test procedure of novel drug substances and products. ICH Q1B is the one that deals with photostability tests. ICH Q1C deals with the stability testing of new dosage forms. ICH Q1D offers a guideline on testing load reduction using bracketed and matrixed designs. ICH Q1E deals with the analysis of the stability data. These are the guidelines that are used to define the conditions of storage, frequency of testing, and minimum levels of data that should be registered in the US, EU, Japan, or any of the other regions that are adopting. Climatic Zones (I-IV) are used to determine the long-term storage conditions depending on the temperature and humidity in the area.
Challenges in Stability Testing
Certain molecules can have a combination of more than one non-linear pathway, and therefore, it is hard to predict shelf life. Challenges in the development of analytical methods: A single method that can isolate the API and all the degradation products of the API can present a very complicated task. The actual shipping and handling (temperature variations, vibration) might not be well represented in the general protocols.
